(429 days)
BELZER-MPSTM, Trans-Med Corporation (K972066)
Not Found
No
The summary describes a chemical solution for organ preservation and does not mention any computational or analytical components that would suggest the use of AI/ML.
No.
The device is a solution used for preserving organs for transplantation, which is a supportive function rather than a direct therapeutic intervention on the patient.
No
The device is a solution for flushing and perfusing kidneys for preservation, not for diagnosing medical conditions.
No
The device description clearly states it is a "clear, sterile, non-pyrogenic, non-toxic solution," which is a physical substance, not software.
Based on the provided information, the PERF-GEN® Pulsatile Perfusion Solution is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for flushing and continuous hypothermic machine perfusion of kidneys at the time of their removal from the donor in preparation for storage, transportation, and eventual transplantation. This is a process performed on the organ itself outside of the body, not on a sample of bodily fluid or tissue to diagnose a condition in a patient.
- Device Description: The description focuses on the chemical composition and properties of the solution used for preserving the organ.
- Lack of Diagnostic Purpose: There is no mention of the device being used to analyze a sample to provide information about a patient's health status, disease, or condition.
IVD devices are typically used to examine samples (like blood, urine, tissue) to provide diagnostic information. The PERF-GEN solution is used to maintain the viability of an organ for transplantation, which is a different purpose.
N/A
Intended Use / Indications for Use
The PERF-GEN® Pulsatile Perfusion Solution is intended to be used for flushing and continuous hypothermic machine perfusion of kidneys at the time of their removal from the donor in preparation for storage, transportation, and eventual transplantation into a recipient.
Product codes (comma separated list FDA assigned to the subject device)
KDL
Device Description
The PERF-GEN® Pulsatile Perfusion (PERF-GEN Solution) is a clear, sterile, non-pyrogenic, non-toxic solution for the in-vitro flushing and temporary continuous perfusion of explanted kidneys. This solution has an approximate calculated osmolarity of 300 mOsm/kg, a sodium concentration of 100 mEq/L, a potassium concentration of 25 mEq/L, and a pH of approximately 7.4 at room temperature.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
kidneys
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The biomaterial safety of the PERF-GEN Solution has been evaluated through 1SO 10993 compliant testing, which included cytotoxicity test, acute systemic toxicity, hemocompatibility, skin sensitization test in guinea pigs, and primary skin irritation. Results of this testing showed the PERF-GEN Solution is safe for the intended biocontact. Test results confirmed that the PERF-GEN Solution is non-cytotoxic, non-toxic, hemocompatible, nongenotoxic, non-sensitizing, and non-irritating.
Results of this stability study confirm that up to 1 year real-time aging at the recommended storage conditions and several months worst-case storage conditions do not affect the product specifications. The stability testing has showed that aging of test articles at the recommended storage conditions does not affect the product specifications for the PERF-GEN labeled with 1-year shelf life.
Chemical composition and properties of the PERF-GEN Solution and the predicate BELZER-MPS solution were compared by infrared, chromatography and conductivity measurements. The infrared spectra, the elution profiles and the ionic strengths of PERF-GEN and BELZER-MPS solutions were compared. The results of those chemical testing confirm that both the PERF-GEN solution and the predicate BELZER-MPS solution are chemically equivalent.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
BELZER-MPSTM, Trans-Med Corporation (K972066)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 876.5880 Isolated kidney perfusion and transport system and accessories.
(a)
Identification. An isolated kidney perfusion and transport system and accessories is a device that is used to support a donated or a cadaver kidney and to maintain the organ in a near-normal physiologic state until it is transplanted into a recipient patient. This generic type of device may include tubing, catheters, connectors, an ice storage or freezing container with or without bag or preservatives, pulsatile or nonpulsatile hypothermic isolated organ perfusion apparatus with or without oxygenator, and disposable perfusion set.(b)
Classification. Class II (performance standards).
0
Traditional 510(k) Premarket Notification PERF-GEN® Pulsatile Perfusion Solution
510(k) Summarv
Date Prepared: December 20th, 2012
Submitter's Name / Contact Person
| Submitter | Contact Person |
|---|---|
| Waters Medical Systems, LLC | Robert Warren |
| 2112 - 15th Street NW | Phone: 507-288-7777 |
| Rochester, Minnesota 55901 | Fax: 507-252-3700 |
| Email: bobw@wtrs.com |
General Information
| Trade Name | PERF-GEN® Pulsatile Perfusion Solution |
|---|---|
| Common / Usual Name | Cold Storage Solution |
| Product Code | KDL |
| Classification Name | Set, perfusion, kidney, disposable |
| Classification Information | 21 CFR 876.5880 |
| Isolated kidney perfusion and transport system and accessories, Class II | |
| Predicate Device | BELZER-MPSTM, Trans-Med Corporation (K972066) |
Device Description
The PERF-GEN® Pulsatile Perfusion (PERF-GEN Solution) is a clear, sterile, non-pyrogenic, non-toxic solution for the in-vitro flushing and temporary continuous perfusion of explanted kidneys. This solution has an approximate calculated osmolarity of 300 mOsm/kg, a sodium concentration of 100 mEq/L, a potassium concentration of 25 mEq/L, and a pH of approximately 7.4 at room temperature.
Intended Use / Indications
The PERF-GEN® Pulsatile Perfusion is intended to be used for flushing and continuous hypothermic machine perfusion of kidneys at the time of their removal from the donor in preparation for storage, transportation, and eventual transplantation into a recipient.
Substantial Equivalence and Summary of Studies
The PERF-GEN Pulsatile Perfusion device is substantially equivalent to the BELZER-MPS UW Machine Perfusion Solution. The PERF-GEN and BELZER-MPS solutions have an identical intended use, chemical composition and principle of operation. Both the subject and predicate device are sterile, non-toxic, transparent solutions dispensed from a bag. Both solutions are sterilized by filtration and aseptically filled in sterile dispensing bags.
The technological difference between PERF-GEN Pulsatile Perfusion compared to the predicate is related to the dispensing bag. The material used for the BELZER-MPS dispensing bags being not specified, it is likely that the bags of PERF-GEN and BELZER-MPS may differ in material. This technological difference has been evaluated
1
through biocompatibility, stability and chemical testing to ensure the possible bag material difference does not impact the specifications of the perfusion solution itself.
The biomaterial safety of the PERF-GEN Solution has been evaluated through 1SO 10993 compliant testing, which included cytotoxicity test, acute systemic toxicity, hemocompatibility, skin sensitization test in guinea pigs, and primary skin irritation. Results of this testing showed the PERF-GEN Solution is safe for the intended biocontact. Test results confirmed that the PERF-GEN Solution is non-cytotoxic, non-toxic, hemocompatible, nongenotoxic, non-sensitizing, and non-irritating.
Results of this stability study confirm that up to 1 year real-time aging at the recommended storage conditions and several months worst-case storage conditions do not affect the product specifications. The stability testing has showed that aging of test articles at the recommended storage conditions does not affect the product specifications for the PERF-GEN labeled with 1-year shelf life.
Chemical composition and properties of the PERF-GEN Solution and the predicate BELZER-MPS solution were compared by infrared, chromatography and conductivity measurements. The infrared spectra, the elution profiles and the ionic strengths of PERF-GEN and BELZER-MPS solutions were compared. The results of those chemical testing confirm that both the PERF-GEN solution and the predicate BELZER-MPS solution are chemically equivalent.
Results of evaluations did not raise any new questions of safety or effectiveness when compared to the predicate device and therefore the PERF-GEN Solution is substantially equivalent to the BELZER-MPS predicate.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features the department's name arranged in a circular fashion around a symbol. The symbol is a stylized representation of an eagle or bird, with three curved lines forming its body and wings. The text is in all caps and reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA".
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
August 16, 2013
Waters Medical Systems, LLC % Robert Warren General Manager 2112 15th Street NW Rochester, MN 55901
Re: K121736
Trade/Device Name: PERF-GEN® Pulsatile Perfusion Solution Regulation Number: 21 CFR§ 876.5880 Regulation Name: Isolated kidney perfusion and transport system and accessories Regulatory Class: II Product Code: KDL Dated: August 1, 2013 Received: August 5, 2013
Dear Robert Warren,
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. or any Fourth all the Act's requirements, including, but not limited to: registration and I ou must occipij marting (21 CFR Part 801); medical device reporting (reporting of
3
Page 2 - Robert Warren
medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Benjamin R. Fisher -S
Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known): K 121736
PERF-GEN® Pulsatile Perfusion Solution Device Name:
Indications for Use:
The PERF-GEN® Pulsatile Perfusion Solution is intended to be used for flushing and continuous hypothermic machine perfusion of kidneys at the time of their removal from the donor in preparation for storage, transportation, and eventual transplantation into a recipient.
Prescription Use >